Drug product
Elelyso (taliglucerase alfa) for injection, 200 units/vial, single-use vial, Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc, NY, NY 10017, NDC 0069-0106-01
D-0005-2019
Product summary
- Firm
- Pfizer Inc.
- Event
- Event 81050
- Status
- Terminated
- Classification
- Class II
- Quantity
- 12,416 vials
- Official record key
drug-enforcement:D-0005-2019
Official wording
Reason: Lack of assurance of sterility -Reports of loose metal ferrule crimps on vials for injection. The entire cap either lifted or dislodged while attempting to flip off the orange color plastic button.
Code information: Lot S91616
Distribution pattern: U.S.A. nationwide. The following countries received product from Lot S91616: Albania, South Africa, Israel, Afghanistan, Rwanda, Botswana, Zimbabwe and Iraq as part of the Compassionate Use Program.
Derived failure modes
-
Sterility assurance
Lack of assurance of sterility